139
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study

, , , , , , , & show all
Pages 193-203 | Published online: 04 Jan 2018

References

  • van EsMAHardimanOChioAAmyotrophic lateral sclerosisLancet2017390101072084209828552366
  • BensimonGLacomblezLMeiningerVALS/Riluzole Study GroupA controlled trial of riluzole in amyotrophic lateral sclerosisN Engl J Med199433095855918302340
  • LacomblezLBensimonGLeighPNA confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-IINeurology1996476 Suppl 4S242S2508959996
  • LacomblezLBensimonGLeighPNGuilletPMeiningerVfor the Amyotrophic Lateral Sclerosis/Riluzole Study Group IIDose-ranging study of riluzole in amyotrophic lateral sclerosisLancet19963479013142514318676624
  • ZoccolellaSBeghiEPalaganoGSLAP RegistryRiluzole and amyotrophic lateral sclerosis survival: a population-based study in southern ItalyEur J Neurol200714326226817355545
  • TraynorKFDA approves edaravone for amyotrophic lateral sclerosisAm J Health Syst Pharm20177412868
  • DyerAMSmithARiluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosisDrug Des Devel Ther2016115964
  • LacomblezLBensimonGLeighPNALS Study Groups I and IILong-term safety of Riluzole in amyotrophic lateral sclerosisAmyotroph Lateral Scler Other Motor Neuron Disord200231232912061945
  • DeboveCZeisserPSalzmanPMPoweLKTruffinetPThe Rilutek (Riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosisAmyotroph Lateral Scler Other Motor Neuron Disord20012315315811771772
  • BensimonGDobleAThe tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosisExpert Opin Drug Saf20043652553415500412
  • CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
  • CookPFSchmiegeSJStarrWCarringtonJMBradley-SpringerLProspective state and trait predictors of daily medication adherence behavior in HIVNurs Res201766427528528654566
  • HaleyWEGilbertONRileyRFSPRINT Study Research GroupThe association between self-reported medication adherence scores and systolic blood pressure control: a SPRINT baseline data studyJ Am Soc Hypertens20161011857.e864.e27697447
  • RajGDHashemiZSoria ContrerasDCAdherence to diabetes dietary guidelines assessed using a validated questionnaire predicts glucose control in individuals with type 2 diabetesCan J Diabetes Epub2017622
  • GetnetAWoldeyohannesSMBekanaLAntiepileptic drug nonadherence and its predictors among people with epilepsyBehav Neurol20162016318910828053370
  • PattiFOptimizing the benefit of multiple sclerosis therapy: the importance of treatment adherencePatient Pref Adherence2010419
  • SendtKVTracyDKBhattacharyyaSA systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disordersPsychiatry Res20152251–2143025466227
  • SabatéEAdherence to Long-Term Therapies: Evidence for Action [dissertation]Geneva, SwitzerlandWorld Health Organization2003
  • BrooksBRMillerRGSwashMMunsatTLWorld Federation of Neurology Research Group on Motor Neuron DiseasesEl Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotroph Lateral Scler Other Motor Neuron Disord20001529329911464847
  • MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)200810534835418453793
  • FabbriniGAbbruzzeseGBaronePREASON Study GroupAdherence to anti-Parkinson drug therapy in the “REASON” sample of Italian patients with Parkinson’s disease: the linguistic validation of the Italian version of the “Morisky Medical Adherence Scale-8 items”Neurol Sci201334112015202223728715
  • Krousel-WoodMAIslamTWebberLSReRSMoriskyDEMuntnerPNew medication adherence scale versus pharmacy fill rates in seniors with hypertensionAm J Manag Care2009151596619146365
  • MoriskyDEDiMatteoMRImproving the measurement of self-reported medication non-adherence: final responseJ Clin Epidemi201164258263
  • BrownMTBussellJKMedication adherence: WHO cares?Mayo Clin Proc201186430431421389250
  • YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
  • FautrelBBalsaAVan RielPInfluence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related)Curr Med Res Opin20173371231124628358217
  • HankinCSCoxLLangDMedical costs and adherence in patients receiving aqueous versus pressurized aerosol formulations of intranasal corticosteroidsAllergy Asthma Proc201233325826422737709
  • U.S. Food and Drug AdministrationDrug Administration RILUTEK®Silver SpringU.S. Food and Drug Administration Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020599s011s012lbl.pdfAccessed November 20, 2017
  • FogartyESchmitzSTubridyNWalshCBarryMComparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: systematic review and network meta-analysisMult Scler Relat Disord20169233027645339
  • DonovanKAGreenePGShusterJLPartridgeEETuckerDCTreatment preferences in recurrent ovarian cancerGynecol Oncol200286220021112144829
  • GaoXNauDPRosenbluthSAScottVWoodwardCThe relationship of disease severity, health beliefs and medication adherence among HIV patientsAIDS Care200012438739811091771
  • ParkHRascatiKLPraslaKMcBayneTEvaluation of health care costs and utilization patterns for patients with goutClin Ther201234364065222381710
  • SarawateCABrewerKKYangWGout medication treatment patterns and adherence to standards of care from a managed care perspectiveMayo Clin Proc200681792593416835972